In the BioHarmony Drug Report Database
Isotretinoin
Absorica, Absorica Ld, Accutane (isotretinoin) is a small molecule pharmaceutical. Isotretinoin was first approved as Absorica on 1982-05-07. It is used to treat acne vulgaris, leukemia, and neuroblastoma in the USA. Amnesteem’s patents are valid until 2035-08-04 (FDA).
Trade Name
|
Absorica, Absorica Ld, Accutane |
|---|---|
Common Name
|
isotretinoin |
ChEMBL ID
|
CHEMBL547 |
Indication
|
acne vulgaris, leukemia, neuroblastoma |
Drug Class
|
Retinol derivatives |
Image (chem structure or protein)